BRAF and melanoma: Consistent with their high mitochondrial metabolism, vemurafenib-resistant cells were more sensitive than parental cells to the lethal effect of the complex IV inhibitor, KCN (Fig. 3B) suggesting that melanoma resistant to BRAF inhibitors largely depend on mitochondrial metabolism for survival.